Citation Impact
Citing Papers
The role of platelet adhesion receptor GPIbα far exceeds that of its main ligand, von Willebrand factor, in arterial thrombosis
2006
A mechanosensory complex that mediates the endothelial cell response to fluid shear stress
2005 StandoutNature
Rationally Designed Integrin β3 Mutants Stabilized in the High Affinity Conformation
2008 StandoutNobel
Edoxaban versus Warfarin for the Treatment of Symptomatic Venous Thromboembolism
2013 Standout
Comparison of 2 hemostatic agents for the prevention of postextraction hemorrhage in patients on anticoagulants
2001
Cytochrome P450 2C19 loss-of-function polymorphism is a major determinant of clopidogrel responsiveness in healthy subjects
2006
Prevention of postoperative bleeding in anticoagulated patients undergoing oral surgery: use of platelet-rich plasma gel
2003
A comparison of prasugrel and clopidogrel loading doses on platelet function: magnitude of platelet inhibition is related to active metabolite formation
2006
ACC/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non–ST-Elevation Myocardial Infarction
2007
Dental extractions in patients on warfarin: is alteration of anticoagulant regime necessary?
1998
Platelets: Physiology and Biochemistry
2005
Mechanisms of Thrombus Formation
2008 Standout
The Dose-Response Relationship of Tranexamic Acid
1995
Increased Active Metabolite Formation Explains the Greater Platelet Inhibition With Prasugrel Compared to High-dose Clopidogrel
2007
Clopidogrel with or without Omeprazole in Coronary Artery Disease
2010 Standout
High Residual Platelet Reactivity After Clopidogrel Loading and Long-term Cardiovascular Events Among Patients With Acute Coronary Syndromes Undergoing PCI
2011
The Systemic Amyloidoses
1997 Standout
A novel functional polymorphism in the PECAM-1 gene (53G>A) is associated with progression of atherosclerosis in the LOCAT and REGRESS studies
2003
Platelet Reactivity After Clopidogrel Treatment Assessed With Point-of-Care Analysis and Early Drug-Eluting Stent Thrombosis
2009
A synthetic peptide vector system for optimal gene delivery to corneal endothelium
2004
Contribution of platelets to tumour metastasis
2011 Standout
Evaluation of prasugrel compared with clopidogrel in patients with acute coronary syndromes: design and rationale for the TRial to assess Improvement in Therapeutic Outcomes by optimizing platelet InhibitioN with prasugrel Thrombolysis In Myocardial Infarction 38 (TRITON-TIMI 38)
2006
Prasugrel achieves greater and faster P2Y12receptor-mediated platelet inhibition than clopidogrel due to more efficient generation of its active metabolite in aspirin-treated patients with coronary artery disease
2007
Aprotinin in primary valve replacement and reconstruction: A multicenter, double-blind, placebo-controlled trial
1996
Nucleotide signalling during inflammation
2014 StandoutNature
Aprotinin Reduces Blood Loss in Patients Undergoing Elective Liver Resection
1997
Fibronectin and integrins in invasion and metastasis
1995
Safety, Tolerability, and Initial Efficacy of AZD6140, the First Reversible Oral Adenosine Diphosphate Receptor Antagonist, Compared With Clopidogrel, in Patients With Non–ST-Segment Elevation Acute Coronary Syndrome
2007
Rivaroxaban in Patients with a Recent Acute Coronary Syndrome
2011 Standout
Pharmacodynamics, pharmacokinetics, and safety of the oral reversible P2Y12 antagonist AZD6140 with aspirin in patients with atherosclerosis: a double-blind comparison to clopidogrel with aspirin
2006
Variability in Individual Responsiveness to Clopidogrel
2007
Bivalirudin during Primary PCI in Acute Myocardial Infarction
2008 Standout
Cytochrome P-450 Polymorphisms and Response to Clopidogrel
2008 Standout
Effects of aprotinin on blood loss, heparin monitoring tests, and heparin doses in patients undergoing coronary artery bypass surgery
1995
Perioperative Management of Antithrombotic Therapy
2012 Standout
Intensive oral antiplatelet therapy for reduction of ischaemic events including stent thrombosis in patients with acute coronary syndromes treated with percutaneous coronary intervention and stenting in the TRITON-TIMI 38 trial: a subanalysis of a randomised trial
2008
Common polymorphisms of CYP2C19 and CYP2C9 affect the pharmacokinetic and pharmacodynamic response to clopidogrel but not prasugrel
2007
Hemostatic effect of n-butyl-2-cyanoacrylate (histoacryl) glue in warfarin-treated patients undergoing oral surgery
2003
Relationship Between Exposure to Prasugrel Active Metabolite and Clinical Outcomes in the TRITON‐TIMI 38 Substudy
2011
The effect of clopidogrel incombination with aspirin whengiven before coronary artery bypass grafting
2002
Levels of sP-selectin and hs-CRP Decrease with Dietary Intervention with Selenium and Coenzyme Q10 Combined: A Secondary Analysis of a Randomized Clinical Trial
2015 StandoutNobel
Early and Sustained Dual Oral Antiplatelet Therapy Following Percutaneous Coronary Intervention
2002 Standout
Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes
2009 Standout
Dental extractions in patients maintained on oral anticoagulant therapy: Comparison of INR value with occurrence of postoperative bleeding
2001
Prasugrel 5 mg in the Very Elderly Attenuates Platelet Inhibition But Maintains Noninferiority to Prasugrel 10 mg in Nonelderly Patients
2013 StandoutNobel
2012 ACCF/AHA Focused Update of the Guideline for the Management of Patients With Unstable Angina/Non–ST-Elevation Myocardial Infarction (Updating the 2007 Guideline and Replacing the 2011 Focused Update)
2012
PLINK: A Tool Set for Whole-Genome Association and Population-Based Linkage Analyses
2007 Standout
Role of von Willebrand factor in tumor metastasis
2007
Platelet function during cardiac surgery and cardiopulmonary bypass with low-dose aprotinin
1999
Role of Prasugrel, a Novel P2Y12 Receptor Antagonist, in the Management of Acute Coronary Syndromes
2009
Platelet Activation and Atherothrombosis
2007 Standout
Characterization of Post-Operative Risk Associated With Prior Drug-Eluting Stent Use
2009
Increased risk of atherothrombotic events associated with cytochrome P450 3A5 polymorphism in patients taking clopidogrel
2006
Pharmacology of Antiplatelet Agents
2013
Microparticles in Cancer
2010
Determinants of the interindividual variability in response to antiplatelet drugs
2005
Recent insights into the role of integrins in cancer metastasis
1998
Influence of aprotinin on early graft thrombosis in patients undergoing myocardial revascularization
1994
Amplified benefit of clopidogrel versus aspirin in patients with diabetes mellitus
2002
Epidemiology of the Antiphospholipid Antibody Syndrome
2000
Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (MATCH): randomised, double-blind, placebo-controlled trial
2004 Standout
Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion
2011 Standout
Immune Thrombocytopenic Purpura
2002 Standout
The Antiphospholipid Syndrome
2002 Standout
Diabetes and Atherosclerosis
2002 Standout
A comprehensive review of genetic association studies
2002
Malignant Gliomas in Adults
2008 Standout
Aprotinin preserves hemostasis in aspirin-treated patients undergoing cardiopulmonary bypass
1994
Modulation of Ocular Surface Glycocalyx Barrier Function by a Galectin-3 N-terminal Deletion Mutant and Membrane-Anchored Synthetic Glycopolymers
2013 StandoutNobel
Emerging Biological Principles of Metastasis
2017 Standout
Initiation of Platelet Adhesion by Arrest onto Fibrinogen or Translocation on von Willebrand Factor
1996 Standout
Guidelines for Percutaneous Coronary Interventions
2005
The Perioperative Management of Antithrombotic Therapy
2008
Impact of the Degree of Peri-Interventional Platelet Inhibition After Loading With Clopidogrel on Early Clinical Outcome of Elective Coronary Stent Placement
2006
Influence of Omeprazole on the Antiplatelet Action of Clopidogrel Associated With Aspirin
2008 Standout
Interindividual variability in the response to oral antiplatelet drugs: a position paper of the Working Group on antiplatelet drugs resistance appointed by the Section of Cardiovascular Interventions of the Polish Cardiac Society, endorsed by the Working Group on Thrombosis of the European Society of Cardiology
2008
Comparison of ticagrelor, the first reversible oral P2Y12 receptor antagonist, with clopidogrel in patients with acute coronary syndromes: Rationale, design, and baseline characteristics of the PLATelet inhibition and patient Outcomes (PLATO) trial
2009
Clopidogrel Loading Dose (300 Versus 600 mg) Strategies for Patients With Stable Angina Pectoris Subjected to Percutaneous Coronary Intervention
2006
Lower cardiac troponin T levels in patients undergoing cardiopulmonary bypass and receiving high-dose aprotinin therapy indicate reduction of perioperative myocardial damage
1995
Prasugrel achieves greater inhibition of platelet aggregation and a lower rate of non-responders compared with clopidogrel in aspirin-treated patients with stable coronary artery disease
2006
Effect of antiplatelet therapy on inflammatory markers in atherothrombotic patients
2009
Tailored Clopidogrel Loading Dose According to Platelet Reactivity Monitoring to Prevent Acute and Subacute Stent Thrombosis
2008
Survey of the year 2003 commercial optical biosensor literature
2004
Low response to clopidogrel is associated with cardiovascular outcome after coronary stent implantation
2006
Risk of Adverse Outcomes Associated With Concomitant Use of Clopidogrel and Proton Pump Inhibitors Following Acute Coronary Syndrome
2009
Clopidogrel Effect on Platelet REactivity in Patients With Stent Thrombosis
2005
Clopidogrel 150 mg/day to Overcome Low Responsiveness in Patients Undergoing Elective Percutaneous Coronary Intervention
2008
Platelets in atherothrombosis: lessons from mouse models
2005
Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion
1999
Integrins
2002 Standout
A dose‐ranging study evaluating the oral factor Xa inhibitor edoxaban for the prevention of venous thromboembolism in patients undergoing total knee arthroplasty
2010
Impact of Platelet Reactivity After Clopidogrel Administration on Drug-Eluting Stent Thrombosis
2007
Increased metastatic potential of tumor cells in von Willebrand factor‐deficient mice
2006
Microenvironmental regulation of tumor progression and metastasis
2013 Standout
Switching directly to prasugrel from clopidogrel results in greater inhibition of platelet aggregation in aspirin-treated subjects
2008
Intensive Insulin Therapy in the Medical ICU
2006 Standout
Efficacy of fibrin sealant in patients on various levels of oral anticoagulant undergoing oral surgery
1998
Management of Diabetes and Hyperglycemia in Hospitals
2004
Prasugrel versus Clopidogrel in Patients with Acute Coronary Syndromes
2007 Standout
Antiplatelet therapy: in search of the 'magic bullet'
2003
Dental extractions in patients maintained on continued oral anticoagulant: Comparison of local hemostatic modalities
1999
Signal Transduction Pathways Mediated by PECAM-1
2003
Extracellular DNA traps promote thrombosis
2010 Standout
A role for factor XIIa–mediated factor XI activation in thrombus formation in vivo
2010
Extracellular vesicles: Exosomes, microvesicles, and friends
2013 Standout
Randomized Comparison of Prasugrel (CS-747, LY640315), a Novel Thienopyridine P2Y 12 Antagonist, With Clopidogrel in Percutaneous Coronary Intervention
2005
Fluorine in Pharmaceutical Industry: Fluorine-Containing Drugs Introduced to the Market in the Last Decade (2001–2011)
2013 Standout
Coordinating Radiometals of Copper, Gallium, Indium, Yttrium, and Zirconium for PET and SPECT Imaging of Disease
2010 Standout
Platelet Function Testing in Cardiovascular Diseases
2004
Aprotinin significantly decreases bleeding and transfusion requirements in patients receiving aspirin and undergoing cardiac operations
1994
Platelet Adhesion Receptors and Their Ligands in Mouse Models of Thrombosis
2007
Contribution of Gene Sequence Variations of the Hepatic Cytochrome P450 3A4 Enzyme to Variability in Individual Responsiveness to Clopidogrel
2006
Response rates and survival in primary systemic amyloidosis
1991
“Low-Dose” Aprotinin Modifies Hemostasis but Not Proinflammatory Cytokine Release
1997
Platelets and platelet adhesion support angiogenesis while preventing excessive hemorrhage
2006
Inhibition of Platelet Aggregation by AZD6140, A Reversible Oral P2Y12Receptor Antagonist, Compared With Clopidogrel in Patients With Acute Coronary Syndromes
2007
Response to Ticagrelor in Clopidogrel Nonresponders and Responders and Effect of Switching Therapies
2010
Platelets at the interface of thrombosis, inflammation, and cancer
2015
Comparaison des effets de l’aprotinine et de l’acide tranexamique sur le saignement en chirurgie cardiaque
1995
A Perspective on Cancer Cell Metastasis
2011 StandoutScience
Nonviral Vectors for Gene Delivery
2008 Standout
Immobilized platelets support human colon carcinoma cell tethering, rolling, and firm adhesion under dynamic flow conditions
2000
The importance of early treatment with tranexamic acid in bleeding trauma patients: an exploratory analysis of the CRASH-2 randomised controlled trial
2011 Standout
Periprocedural bridging therapy in patients receiving chronic oral anticoagulation therapy
2006
Chromone: A Valid Scaffold in Medicinal Chemistry
2014 Standout
Is ε-Aminocaproic Acid as Effective as Aprotinin in Reducing Bleeding With Cardiac Surgery?
1999
Clopidogrel Loading With Eptifibatide to Arrest the Reactivity of Platelets
2005
ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease
2006 Standout
Management of Venous Thromboembolism in Patients With Primary and Metastatic Brain Tumors
2006
Comparison of Platelet Function Tests in Predicting Clinical Outcome in Patients Undergoing Coronary Stent Implantation
2010
Prasugrel Compared With High Loading- and Maintenance-Dose Clopidogrel in Patients With Planned Percutaneous Coronary Intervention
2007
Nonvalvular Cardiovascular Device–Related Infections
2003
Immobilized platelets support human colon carcinoma cell tethering, rolling, and firm adhesion under dynamic flow conditions
2000
Platelet Glycoprotein IIb/IIIa Inhibitors Reduce Mortality in Diabetic Patients With Non–ST-Segment-Elevation Acute Coronary Syndromes
2001
Increased surface expression of the membrane glycoprotein IIb/IIIa complex induced by platelet activation. Relationship to the binding of fibrinogen and platelet aggregation
1987
The effect of clopidogrel in combination with aspirin when given before coronary artery bypass grafting
2002
Anti-GPIIb/IIIa Drugs: Current Strategies and Future Directions
2001
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
2014 Standout
Lysis of tumor cells by natural killer cells in mice is impeded by platelets.
1999
Clinical Aspects of Platelet Inhibitors and Thrombus Formation
2007
PTEN , a Putative Protein Tyrosine Phosphatase Gene Mutated in Human Brain, Breast, and Prostate Cancer
1997 StandoutScience
Putting polyphosphates to the test: evidence against platelet-induced activation of factor XII
2013 StandoutNobel
2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation
2015 Standout
In vivo roles of factor XII
2012
Cytochrome P450 Genetic Polymorphisms and the Response to Prasugrel
2009
Surface Plasmon Resonance Sensors for Detection of Chemical and Biological Species
2008 Standout
Percutaneous coronary intervention in diabetic patients with non-ST-segment elevation acute coronary syndromes
2004
ACCF/AHA Clopidogrel Clinical Alert: Approaches to the FDA “Boxed Warning”
2010
Comparison of the effects of aprotinin and tranexamic acid on blood loss and related variables after cardiopulmonary bypass
1994
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial
2010 Standout
Atherosclerosis: process, indicators, risk factors and new hopes.
2014
Integrin-mediated cell adhesion: the extracellular face.
1994
Tranexamic acid mouthwash versus autologous fibrin glue in patients taking warfarin undergoing dental extractions: a randomized prospective clinical study
2003
Monitoring of Clopidogrel Action: Comparison of Methods
2005
Aprotinin Has no Effect on Platelet Activation and Adhesion during Cardiopulmonary Bypass
1996
Clopidogrel Response Variability and Future Therapies
2006
Adhesion Mechanisms in Platelet Function
2007
Preoperative Platelet Dysfunction Increases the Benefit of Aprotinin in Cardiopulmonary Bypass
1997
Weekend versus Weekday Admission and Mortality from Myocardial Infarction
2007 Standout
The molecular immunology of human platelet proteins
1992
Effect of prophylactic epsilon-aminocaproic acid on blood loss and transfusion requirements in patients undergoing first-time coronary artery bypass grafting. A randomized, prospective, double-blind study.
1994
Cell Surface O-Glycans LimitStaphylococcus aureusAdherence to Corneal Epithelial Cells
2008
2012 ACCF/AHA Focused Update Incorporated Into the ACCF/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non–ST-Elevation Myocardial Infarction
2013
Works of David Varon being referenced
Dental extraction for patients on oral anticoagulant therapy
1990
Dental extractions in patients with bleeding disorders
1993
High incidence of thromboembolism in patients with central nervous system lymphoma
2003
Platelet protection by low-dose aprotinin in cardiopulmonary bypass: Electron microscopic study
1993
Factors Associated with Bleeding in Elderly Hospitalized Patients Treated with Enoxaparin Sodium
2008
Platelets mediate tumor cell adhesion to the subendothelium under flow conditions: Involvement of platelet GPIIb-IIIa and tumor cell ?v integrins
1997
Shear-Induced Platelet Adhesion and Aggregation on Subendothelium Are Increased in Diabetic Patients
1998
Structural analysis of integrin recognition and the inhibition of integrin-mediated cell functions by novel nonpeptidic surrogates of the Arg-Gly-Asp sequence
1993
Molecular characterization of an human monoclonal antibody that interacts with a sulfated tyrosine-containing epitope of the GPIb receptor and inhibits platelet functions
2005
Human monoclonal antibody derived from an autoimmune thrombocytopenic purpura patient, recognizing an intermediate filament's determinant common to vimentin and desmin
1990
Comparison of Platelet Function and Morphology in Patients Undergoing Percutaneous Coronary Intervention Receiving Bivalirudin Versus Unfractionated Heparin Versus Clopidogrel Pretreatment and Bivalirudin
2007
Platelet‐derived microparticles promote invasiveness of prostate cancer cells via upregulation of MMP‐2 production
2008
Primary amyloidosis with unusual bone involvement: Reversibility with melphalan, prednisone, and colchicine
1989
Patients with severe factor XI deficiency have a reduced incidence of deep-vein thrombosis
2010
Abciximab in Carotid Stenting for Postsurgical Carotid Restenosis: Intermediate Results
2000
C‐reactive protein promotes platelet adhesion to endothelial cells: a potential pathway in atherothrombosis
2006
The Combining Ability of Glycoproteins IIb, IIIa and Ca2+ in EDTA-Treated Nonaggregable Platelets
1983
Clopidogrel Resistance Is Associated With Increased Risk of Recurrent Atherothrombotic Events in Patients With Acute Myocardial Infarction
2004
Platelet/Endothelial Cell Adhesion Molecule-1 Serves as a Costimulatory Agonist Receptor That Modulates Integrin-Dependent Adhesion and Aggregation of Human Platelets
1998
Adherence Properties of Staphylococcus aureus under Static and Flow Conditions: Roles of agr and sar Loci, Platelets, and Plasma Ligands
2001
Single and Combined Prothrombotic Factors in Patients With Idiopathic Venous Thromboembolism
1999
Thrombospondin‐1 mediates platelet adhesion at high shear via glycoprotein Ib (GPIb): an alternative/backup mechanism to von Willebrand factor
2003
Role of platelet-derived microparticles in angiogenesis and tumor progression.
2009
Recombinant von Willebrand Factor Fragment AR545C Inhibits Platelet Aggregation and Enhances Thrombolysis With rtPA in a Rabbit Thrombosis Model
1998
Patients with Severe Factor XI Deficiency Have a Reduced Incidence of Venous Thromboembolism.
2009
The Efficacy and Safety of Perioperative Low Molecular Weight Heparin Substitution in Patients on Chronic Oral Anticoagulant Therapy Undergoing Transurethral Prostatectomy for Bladder Outlet Obstruction
2002